Denodo Adds to Executive Team with Key Appointments: Daniel Lender Joins as Chief Financial Officer and Stephen Welles as Chief Legal Officer
Denodo, a leader in data management, today announced two key additions to its executive team to help to guide Denodo through its next phase of growth: Daniel Lender as Chief Financial Officer and Stephen Welles as Chief Legal Officer. Mr. Lender and Mr. Welles will lead all of Denodo’s global financial and legal strategy and operations, reporting directly to Denodo’s Chief Executive Officer, Angel Viña.
“We’re excited to welcome Daniel as our new CFO and Stephen as our new CLO,” said Angel Viña, CEO and Founder of Denodo. “Daniel brings extensive financial and operational experience in enterprise software to our executive team and Stephen adds his broad and deep expertise in legal matters. These two key appointments strengthen our executive team and will be a great asset to Denodo as we continue to grow our global business.”
Daniel Lender is the newest addition to Denodo’s executive leadership team and brings more than 30 years of enterprise software and financial markets experience to his role. Mr. Lender joins Denodo after a long tenure with QAD Inc., a leading provider of next generation manufacturing and supply chain management solutions in the cloud, where he served as executive vice president and chief financial officer.
“I am absolutely thrilled to join Denodo at this stage,” said Daniel Lender. “With data growing at an exponential rate and multi-cloud platforms becoming the norm, I believe Denodo, with its unique and proprietary platform, is well positioned to continue its growth path and help its customers unlock value from their data. I look forward to working with the Denodo leadership team to help fuel Denodo’s next phase of growth.”
Stephen Welles brings more than 25 years of experience to his new position as Chief Legal Officer. He joined Denodo from Wilson Sonsini Goodrich & Rosati, the premier legal advisor to technology, life sciences, and other growth enterprises worldwide, where he was a senior counsel. Before that, he was the senior vice president and general counsel at Oplink Communications, an optical networking equipment company with more than 3,000 employees worldwide.
“Denodo has a bright future and I am excited to be a part of the team,” said Stephen Welles. “Denodo’s mission to help enterprises become data-driven organizations is an important one, and it will continue to drive Denodo’s growth.”
Denodo was recognized as a Leader in the 2022 Gartner® Magic Quadrant™ for Data Integration Tools for a third year in a row, and in the Forrester Wave™: Enterprise Data Fabric, Q2 2022 for a second year in a row. Denodo is the fastest growing vendor among the top 10 data integration vendors according to Gartner Market Share Analysis: Data Integration Software, Worldwide, 2021. Denodo also has been consistently receiving Customers’ Choice distinction in the Gartner Peer Insights 'Voice of the Customer': Data Integration Tools report for the last two years, showcasing how positively Denodo customers perceive the value of the product, services and support offered by Denodo.
Please tweet: News: @denodo adds to executive team - Daniel Lender as Chief Financial Officer and Stephen Welles as Chief Legal Officer to drive next phase of growth for #datamanagement and #dataintegration leader
About Denodo
Denodo is a leader in data management. The award-winning Denodo Platform is the leading data integration, management, and delivery platform using a logical approach to enable self-service BI, data science, hybrid/multi-cloud data integration, and enterprise data services. Realizing more than 400% ROI and millions of dollars in benefits, Denodo’s customers across large enterprises and mid-market companies in 30+ industries have received payback in less than 6 months. For more information, visit www.denodo.com or call +1 877 556 2531 (US) / +44 (0) 20 7869 8053 (UK) / +65 6950 7489 (Singapore).
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221109005616/en/
Contact information
Chris McCoin or Richard Smith
McCoin & Smith Communications Inc.
508-429-5988 (Chris) or 978-433-3304 (Rick)
chris@mccoinsmith.com or rick@mccoinsmith.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New York Liberty and Ant International’s Alipay+ Announce Multiyear Partnership Focused on Empowerment, Sustainability and Youth Development19.12.2025 15:30:00 EET | Press release
The New York Liberty and Ant International’s Alipay+, a leading cross-border fintech services platform based in Singapore, today announced a multiyear partnership, making Alipay+ an Official Sponsor and Innovation Partner for Sustainability of the New York Liberty. Through this partnership, Alipay+ and the Liberty will jointly support community programs designed to advance community empowerment, environmental sustainability and youth development across New York City. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219678825/en/ Peng Yang, CEO, Ant International and Clara Wu Tsai, Vice Chair, Brooklyn Sports and Entertainment; Governor, New York Liberty “Our partnership with Alipay+ goes beyond the game,” said Keia Clarke, Chief Executive Officer, New York Liberty. “Together, we are investing in the future of New York—its people, its environment, and its youth. Ant International’s commitment to community empowerment, sustai
Parse Biosciences and Codebreaker Labs Partner to Apply Whole Transcriptome Single Cell Profiling and Causal Genomics at Scale19.12.2025 15:00:00 EET | Press release
Parse Biosciences, the leading provider of scalable and accessible single cell sequencing solutions, today announced a collaboration with Codebreaker Labs to develop and validate a breakthrough platform capable of testing thousands of genetic variants in parallel and measuring their effects at single cell resolution. By combining Codebreaker’s synthetic biology platform and variant engineering capabilities with the scale and accessibility of Parse’s Evercode™ technology, the collaboration aims to generate the causal data increasingly sought by AI developers, drug discovery teams, and clinical researchers. Today’s genomic studies rely heavily on observational data, or variants that appear in large populations. But rare and private variants, often only seen in one individual or family, are nearly impossible to study this way because too few carriers of the variant exist to draw statistically meaningful conclusions. As a result, even the most advanced models trained on observational datas
Cyviz Awarded Two Classified NATO Defense Contracts19.12.2025 09:00:00 EET | Press release
Norwegian technology and platform company Cyviz AS has been awarded two classified defense contracts by major European NATO-partner nations to deliver a fully mobile, containerised Command & Control (C2) capability, strengthening Europe’s operational readiness in high-threat and expeditionary environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218625485/en/ Image from a previous military exercise where Cyviz demonstrated a mobile command center solution. The contracts cover the design, integration, and delivery of secure, deployable operations centres engineered to NATO security standards, enabling military and security forces to establish full theatre-class command capability wherever operations require. Due to the sensitive nature of the missions, contract value and customer identities remain undisclosed. From Demonstrated Readiness to Operational Deployment The awards follow growing interest among European def
S3NS Announces SecNumCloud Qualification for PREMI3NS, its Trusted Cloud Offering19.12.2025 08:00:00 EET | Press release
S3NS, a subsidiary of Thales in partnership with Google Cloud, today announced that PREMI3NS, its "Trusted Cloud" (Cloud de confiance) offering, has received the SecNumCloud 3.2 qualification delivered by the French National Agency for the Security of Information Systems (ANSSI). Meeting SecNumCloud 3.2’s protection and resilience requirements, which are known as the most demanding ones in France and Europe, it offers immunity from non-European extraterritorial laws. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218817208/en/ ANSSI delivered the SecNumCloud 3.2 qualification for S3NS’ PREMI3NS offering, meeting all its requirements and passing all three milestones of the qualification process. With PREMI3NS, S3NS now offers businesses and public sector organizations the most extensive cloud service among the offerings that have received the SecNumCloud 3.2 qualification. PREMI3NS integrates the most advanced IaaS and Paa
Meiji Seika Pharma Partners With MBC BioLabs to Strengthen Global Innovation in Drug Discovery19.12.2025 03:00:00 EET | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo; President & CEO: Toshiaki Nagasato) today announced that it has entered into a partnership agreement with MBC BioLabs which is a private organization supporting the development of biotech startup companies in California’s San Francisco Bay Area. MBC BioLabs provides fully equipped research facilities and a supportive community that help biotech entrepreneurs accelerate from concept to company. By removing the burden of building and maintaining laboratory infrastructure, resident companies can focus early on research and development while efficiently advancing commercialization. Through this partnership, Meiji Seika Pharma will further advance its open-innovation initiatives and strengthen research and development in its priority therapeutic areas: infectious diseases, hematologic diseases, and immune-inflammatory diseases. By engaging with the entrepreneurs and startup community at MBC BioLabs, the company aims to discover inn
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom